| Multiple | Now | Sector median | Where it sits |
|---|---|---|---|
| P/E | −1.2× | −1.8× | |
| Price / Book | 1.7× | 2.1× | |
| Price / Sales | — | 4.0× | — |
| Price / Free cash flow | −0.0× | −1.6× | |
| EV / EBITDA | −0.5× | −1.2× | |
| Earnings yield | −85.9% | −14.0% | |
| Free cash flow yield | −84,106,701.1% | −9.5% |
| Company | Price | Change | Mkt cap (USD) | P/E | ROE | 1Y |
|---|---|---|---|---|---|---|
LLNYSE:LLYEli Lilly and Co · 🇺🇸 NYSE | $1,266.62 | −3.07% | $1.19T | 59.6× | 77.8% | +21.1% |
JNNYSE:JNJJohnson & Johnson · 🇺🇸 NYSE | $263.17 | −1.66% | $633.53B | 24.0× | 32.9% | +39.5% |
ABNYSE:ABBVAbbVie Inc · 🇺🇸 NYSE | $285.73 | +0.19% | $504.92B | 119.3× | −129.2% | +23.3% |
UNNYSE:UNHUnitedHealth Group Inc · 🇺🇸 NYSE | $417.85 | −1.68% | $375.06B | 31.6× | 12.8% | +16.3% |
MRNYSE:MRKMerck & Co Inc · 🇺🇸 NYSE | $144.81 | −1.65% | $357.27B | 19.9× | 34.7% | +68.0% |
NVNYSE:NVSNovartis AG · 🇺🇸 NYSE | $149.47 | −4.35% | $269.34B | 20.0× | 30.5% | +19.0% |
AZNYSE:AZNAstraZeneca PLC · 🇺🇸 NYSE | $171.18 | −0.81% | $265.48B | 26.1× | 21.1% | +3.3% |
TMNYSE:TMOThermo Fisher Scientific Inc · 🇺🇸 NYSE | $670.65 | −0.87% | $247.97B | 37.1× | 12.6% | +21.2% |
AMNAS:AMGNAmgen Inc · 🇺🇸 NAS | $440.79 | −1.45% | $238.31B | 31.4× | 89.1% | +48.5% |
GINAS:GILDGilead Sciences Inc · 🇺🇸 NAS | $156.51 | −0.43% | $194.07B | 22.9× | 37.5% | +26.7% |
